T. Rowe Price Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.47M | Sell |
|
|||||
|
2025
Q2 | $3.64M | Sell |
|
|||||
|
2025
Q1 | $8.01M | Sell |
|
|||||
|
2024
Q4 | $19.4M | Sell |
|
|||||
|
2024
Q3 | $29.1M | Sell |
|
|||||
|
2024
Q2 | $27.9M | Sell |
|
|||||
|
2024
Q1 | $78.1M | Buy |
|
|||||
|
2023
Q4 | $26.6M | Sell |
|
|||||
|
2023
Q3 | $16.4M | Sell |
|
|||||
|
2023
Q2 | $25.8M | Sell |
|
|||||
|
2023
Q1 | $22.9M | Sell |
|
|||||
|
2022
Q4 | $24.6M | Sell |
|
|||||
|
2022
Q3 | $45.1M | Buy |
|
|||||
|
2022
Q2 | $48M | Sell |
|
|||||
|
2022
Q1 | $85.9M | Buy |
|
|||||
|
2021
Q4 | $89M | Buy |
|
|||||
|
2021
Q3 | $114M | Sell |
|
|||||
|
2021
Q2 | $121M | Sell |
|
|||||
|
2021
Q1 | $163M | Sell |
|
|||||
|
2020
Q4 | $343M | Buy |
|
|||||
|
2020
Q3 | $228M | Sell |
|
|||||
|
2020
Q2 | $200M | Buy |
|
|||||
|
2020
Q1 | $203M | Buy |
|
|||||
|
2019
Q4 | $180M | Buy |
|
|||||
|
2019
Q3 | $118M | Buy |
|
|||||
|
2019
Q2 | $148M | Buy |
|
|||||
|
2019
Q1 | $33.2M | Buy |
|
|||||
|
2018
Q4 | $29.2M | Buy |
|
|||||
|
2018
Q3 | $35.1M | Sell |
|
|||||
|
2018
Q2 | $42.1M | Buy |
|
|||||
|
2018
Q1 | $29.5M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $3.96M | Buy |
|